CAPITAL COUNSEL LLC/NY

Position in AMGN — Amgen Inc

CIK 1114928 NEW YORK, NY

Position in AMGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$241,171

+$6,839 QoQ

Shares Held

666

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#2,710

of 3,140 holders

Holding Since

Mar 2020

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CAPITAL COUNSEL LLC/NY holds $16,265,242 across 4 Drug Manufacturers - General names. AMGN ranks #3 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	68,928	$8,708,363
2	MRK	Merck & Co., Inc.	55,363	$7,114,145
3	AMGN	Amgen Inc This page	666	$241,171
4	ABBV	AbbVie Inc.	801	$201,563

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$241,171	666	0.0%	Shares	Sole	2026-08-12
2026-03-31	$234,332	666	0.0%	Shares	Sole	2026-05-15
2025-12-31	$217,988	666	-2.9%	Shares	Sole	2026-02-12
2025-03-31	$213,723	686	+3.0%	Shares	Sole	2025-05-14
2024-09-30	$214,591	666	0.0%	Shares	Sole	2024-11-13
2024-06-30	$208,091	666	-59.0%	Shares	Sole	2024-08-14
2023-03-31	$392,843	1,625	0.0%	Shares	Sole	2023-05-15
2022-12-31	$426,790	1,625	0.0%	Shares	Sole	2023-02-09
2022-09-30	$366,275	1,625	0.0%	Shares	Sole	2022-11-14
2022-06-30	$395,362	1,625	0.0%	Shares	Sole	2022-08-15
2022-03-31	$392,957	1,625	0.0%	Shares	Sole	2022-05-16
2021-12-31	$365,576	1,625	0.0%	Shares	Sole	2022-02-14
2021-09-30	$345,556	1,625	0.0%	Shares	Sole	2021-11-12
2021-06-30	$396,093	1,625	-5.8%	Shares	Sole	2021-08-12
2021-03-31	$429,197	1,725	0.0%	Shares	Sole	2021-05-12
2020-12-31	$396,612	1,725	0.0%	Shares	Sole	2021-02-10
2020-09-30	$438,426	1,725	0.0%	Shares	Sole	2020-11-16
2020-06-30	$406,858	1,725	+6.2%	Shares	Sole	2020-08-14
2020-03-31	$329,436	1,625	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.